Isocitrate Dehydrogenase Mutations in Cancer: From Bench to Bedside Applications
Mutant isocitrate dehydrogenase affects multiple cancer types. Alterations in IDH1 and IDH2 result in abnormal enzyme activity, leading to the overproduction of D‐2‐hydroxyglutarate (D‐2HG). This metabolite disrupts cellular metabolism and epigenetic regulation, driving cancer initiation, progression, and metastasis.
Yuhan Fang +6 more
wiley +1 more source
Combination therapy with tobevibart and elebsiran potently reduces hepatitis B virus surface antigen levels in preclinical <i>in vivo</i> models. [PDF]
Noack J +11 more
europepmc +1 more source
HBV RNA at 6 months after nucleos(t)ide analogues treatment can predict antiviral efficacy in chronic hepatitis B patients. [PDF]
Xie Y +14 more
europepmc +1 more source
Distribution of domestic cat hepatitis B virus in cholangiocarcinoma and non-neoplastic liver tissue. [PDF]
Dosaka H +9 more
europepmc +1 more source
A retrospective study of preoperative HBsAg levels predicting recurrence after curative resection in patients with HBV-associated hepatocellular carcinoma. [PDF]
Xu R +9 more
europepmc +1 more source
Tenofovir Alafenamide Fumarate Reduces Virological Replication in HBeAg-Negative Patients With Normal Alanine Aminotransferase: A 48-Week Randomised Controlled Trial. [PDF]
Luo Q +11 more
europepmc +1 more source
Vaccine expression systems and maternal/neonatal factors: Impacts on hepatitis B immunization efficacy in preterm infants. [PDF]
Shen L +7 more
europepmc +1 more source

